Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
174M
-
Shares change
-
-6.77M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
-$70.7M
-
Put/Call ratio
-
0.07
-
Number of buys
-
81
-
Number of sells
-
-95
-
Price
-
$9.00
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q3 2020
220 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q3 2020.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 174M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (22.3M shares), BROWN CAPITAL MANAGEMENT LLC (20.1M shares), VANGUARD GROUP INC (15.8M shares), BlackRock Inc. (14.1M shares), Sarissa Capital Management LP (14M shares), STATE STREET CORP (7.98M shares), Camber Capital Management LP (7.25M shares), Camber Capital Management LP (7.25M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (6.85M shares), and FMR LLC (3.83M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.